
    
      The Effect of Bosentan and Pioglitazone on Insulin Resistance in Pulmonary Arterial
      Hypertension ,is a study evaluating the incidence of insulin resistance in patients with
      pulmonary hypertension and testing the utility of a validated PH therapy(Tracleer) versus
      Pioglitazone in the treatment of those patients found to have insulin resistance.Patients
      with PAH must be stable on therapy for at least 3 months are considered for enrollment in
      this study.With the exception of PAH, subjects must be free of major medical illnesses,
      including diabetes mellitus ,malignancy or significant hepatic or renal disease.
    
  